- Topic1/3
10k Popularity
59k Popularity
12k Popularity
20k Popularity
982 Popularity
- Pin
- #Gate 2025 Semi-Year Community Gala# voting is in progress! 🔥
Gate Square TOP 40 Creator Leaderboard is out
🙌 Vote to support your favorite creators: www.gate.com/activities/community-vote
Earn Votes by completing daily [Square] tasks. 30 delivered Votes = 1 lucky draw chance!
🎁 Win prizes like iPhone 16 Pro Max, Golden Bull Sculpture, Futures Voucher, and hot tokens.
The more you support, the higher your chances!
Vote to support creators now and win big!
https://www.gate.com/announcements/article/45974
- 🎉 Hey Gate Square friends! Non-stop perks and endless excitement—our hottest posting reward events are ongoing now! The more you post, the more you win. Don’t miss your exclusive goodies! 🚀
1️⃣ #ETH Hits 4800# | Market Analysis & Prediction: Boldly share your ETH predictions to showcase your insights! 10 lucky users will split a 0.1 ETH prize!
Details 👉 https://www.gate.com/post/status/12322612
2️⃣ #Creator Campaign Phase 2# |ZKWASM Topic: Share original content about ZKWASM or its trading activity on X or Gate Square to win a share of 4,000 ZKWASM!
Details 👉 https://www.gate.com/post/st
Bai Aotai: Signed authorization, production, supply, and commercialization protocol for BAT2306 (sukunumab) injection with Stein.
On December 16th, Jinshi Data News, the company signed an authorization license with SteinCares for the production, supply, and commercialization of the protocol, granting Stein the exclusive commercialization rights for the company's BAT2306 (Sikuchenyou monoclonal antibody) injection solution in the Brazilian and other Latin American markets. The transaction amount is up to a maximum of $8 million, including a $1.2 million down payment, a cumulative milestone payment of no more than $6.8 million, and a double-digit percentage of net sales as revenue sharing.